EGR1 and plasma cell myeloma: In contrast, another patient with an NTRK1 fusion, MMRF 2490, had clonal mutations in well-known myeloma tumor suppressors EGR1 and DIS3, meaning that targeting the NTRK1 fusion alone may not have been sufficient.